Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Pi Xu San Hao Fang (脾虚三号方) is a traditional Chinese medicine (TCM) formula. The name translates to "Spleen Deficiency Formula No. 3," indicating it is designed for the treatment of conditions associated with spleen deficiency according to TCM theory. Spleen deficiency in TCM often manifests as fatigue, poor appetite, loose stools, and general digestive weakness. The specific herbal composition and mechanism of action for this formula are not available in the provided sources or widely documented in English-language literature or major Chinese medical databases accessible via the search results. Based on standard TCM practice, formulas named with "San Hao Fang" (No. 3 Formula) are typically custom modifications or institutional prescriptions rather than classical formulas found in ancient texts. They may combine herbs that tonify the spleen qi, support digestion, and harmonize other organ systems depending on clinical presentation. There is no evidence from the search results that this formula has been studied in Western-style clinical trials or approved by regulatory agencies outside China.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Pi Xu San Hao Fang.